Sargazi Saman, Laraib Ushna, Er Simge, Rahdar Abbas, Hassanisaadi Mohadeseh, Zafar Muhammad Nadeem, Díez-Pascual Ana M, Bilal Muhammad
Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 98167-43463, Iran.
Department of Pharmacy, College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Nanomaterials (Basel). 2022 Mar 27;12(7):1102. doi: 10.3390/nano12071102.
Nanoparticles are currently used for cancer theranostics in the clinical field. Among nanoparticles, gold nanoparticles (AuNPs) attract much attention due to their usability and high performance in imaging techniques. The wide availability of biological precursors used in plant-based synthesized AuNPs allows for the development of large-scale production in a greener manner. Conventional cancer therapies, such as surgery and chemotherapy, have significant limitations and frequently fail to produce satisfying results. AuNPs have a prolonged circulation time, allow easy modification with ligands detected via cancer cell surface receptors, and increase uptake through receptor-mediated endocytosis. To exploit these unique features, studies have been carried out on the use of AuNPs as contrast agents for X-ray-based imaging techniques (i.e., computed tomography). As nanocarriers, AuNPs synthesized by nontoxic and biocompatible plants to deliver therapeutic biomolecules could be a significant stride forward in the effective treatment of various cancers. Fluorescent-plant-based markers, including AuNPs, fabricated using , , , and , have been used in detecting cancers. Moreover, green synthesized AuNPs using various extracts have been applied for the treatment of different types of solid tumors. However, the cytotoxicity of AuNPs primarily depends on their size, surface reactivity, and surface area. In this review, the benefits of plant-based materials in cancer therapy are firstly explained. Then, considering the valuable position of AuNPs in medicine, the application of AuNPs in cancer therapy and detection is highlighted with an emphasis on limitations faced by the application of such NPs in drug delivery platforms.
目前,纳米颗粒在临床领域用于癌症的诊断与治疗。在纳米颗粒中,金纳米颗粒(AuNPs)因其在成像技术中的可用性和高性能而备受关注。植物合成AuNPs所使用的生物前体来源广泛,这使得以更环保的方式进行大规模生产成为可能。传统的癌症治疗方法,如手术和化疗,存在显著局限性,且常常无法取得令人满意的效果。AuNPs具有较长的循环时间,易于通过癌细胞表面受体检测到的配体进行修饰,并通过受体介导的内吞作用增加摄取。为了利用这些独特特性,人们开展了关于将AuNPs用作基于X射线成像技术(即计算机断层扫描)的造影剂的研究。作为纳米载体,由无毒且生物相容性良好的植物合成的AuNPs用于递送治疗性生物分子,这可能是在有效治疗各种癌症方面向前迈出的重要一步。使用[具体方法1]、[具体方法2]、[具体方法3]和[具体方法4]制备的包括AuNPs在内的基于植物的荧光标记物已用于癌症检测。此外,使用各种提取物绿色合成的AuNPs已应用于不同类型实体瘤的治疗。然而,AuNPs的细胞毒性主要取决于其大小、表面反应性和表面积。在这篇综述中,首先解释了基于植物的材料在癌症治疗中的益处。然后,考虑到AuNPs在医学中的重要地位,重点强调了AuNPs在癌症治疗和检测中的应用以及此类纳米颗粒在药物递送平台应用中面临的局限性。